Lumares Strategy
Medical Strategy. Agile, Value-led Impact. Scientific Insight.
LUMARES Strategy provides senior-level scientific and Medical Affairs expertise to biopharma at critical inflection points of development, launch and expansion.
We support leaders navigating complex scientific decisions under pressure, from early development through launch readiness, indication expansion and lifecycle optimisation.
Combining deep scientific expertise with strategic leadership to strengthen agile decision-making, accelerate progress meaningfully, and drive measurable impact so that medical strategy is fully integrated with evidence requirements, regulatory realities, and critical unmet medical needs.
​
This integrated, impact-led approach has supported multiple high stakes programmes across diverse therapeutic areas, including complex novel platform technologies and global launches delivered with rapid speed, high scientific integrity, strategic medical impact, and regulatory and value alignment.
​​​
How We Support You
Medical Strategy. Agile, Value-led Impact. Scientific Insight.
LUMARES supports biopharma organisations at critical inflection points, providing senior-level scientific and Medical Affairs leadership that strengthens decision-making, accelerates progress meaningfully, and drives measurable impact.
We work across three core moments:
Early-stage strategy and scientific positioning
Senior scientific and medical strategy embedded early to shape evidence requirements, positioning, and development decisions. We prevent downstream rework by integrating medical insight, regulatory realities, and unmet need from the outset to de-risk and accelerate development.
Launch readiness and first-launch execution
Focused, senior-led launch readiness support to stress-test medical strategy, field readiness, and evidence plans. We identify gaps early, align teams fast, and ensure Medical Affairs drives impact rather than operating in isolation.
Post-launch optimisation and indication expansion
Strategic medical leadership to support indication expansion, portfolio evolution, and post-launch optimisation. We strengthen decision-making across evidence, medical execution, and organisational priorities to sustain momentum and value.
AI-enabled Medical Affairs Support
​As Medical Affairs enters a new era of complexity, data volume, and AI-driven scientific environments, we support leaders in understanding how their functions must evolve, helping organisations modernise insight pathways, decision quality and strategic capability in preparation for the upcoming years of AI integration.
Who We Are
LUMARES Strategy is built on decades of senior in-house global leadership from small biotechs to large biopharma, anchored by deep scientific expertise across diverse platform launches and therapeutic areas.
​
We are not a typical consultancy. With significant senior-leadership experience in Medical Affairs at local, regional and global level, we deliver agile, senior-led strategy navigating complexity, expansion, or development change, with strategic impact at the core of our activities.
Our proven track record includes high stakes launches delivered at unprecedented speed, capability and organisational builds in Medical Affairs from early development through launch and beyond, and scientific strategy consistently grounded in robust evidence and external credibility.
​
This matters because, for novel, first-in-class, or highly differentiated products, success is rarely driven by execution alone. It depends on the quality of decisions made early, the timing and focus of Medical Affairs involvement, and whether capabilities are designed to support the right scientific, regulatory, payer, and stakeholder needs in the right regions, for the right strategy, and at the right moment.
​
We understand how the Medical Affairs function is evolving, including the impact of AI and advanced analytics on insight generation, evidence strategy, and decision-making. We support organisations in evolving capabilities, insight processes, and governance frameworks so Medical Affairs remains competitive, resilient, and future-ready, not just active.
​
Our proprietary frameworks are designed to support better decisions, credible scientific communication, improved stakeholder trust, and measurable outcomes aligned with corporate priorities — including launch readiness, external credibility, and long-term value creation.
Our scientific expertise spans multiple therapeutic areas, including neurology, cardiometabolic disease, immuno-oncology, RNA therapeutics, and infectious diseases, allowing us to bring pattern recognition and judgement across indications, platforms, and development stages.
At LUMARES, we support organisations at the critical inflection points where decisions, evidence, credibility, and timing determine outcomes.
Medical Strategy. Agile, Value-led Impact. Scientific Insight.
The Lumares Difference
Scientific Insight. Integrated Strategy. Value-led Impact.​
​
LUMARES Strategy is built on decades of senior, in-house leadership across small biotechs and biopharma, combining deep scientific authority with hands-on Medical Affairs execution at the highest level.
What differentiates LUMARES is not only what we do, but where and how we have led.
C-Suite and Board-Level Medical Leadership
LUMARES brings experience operating from affiliate level to the highest levels of organisational decision-making, with direct accountability to C-suite leaders and boards. This perspective ensures medical strategy is aligned not only to scientific and clinical priorities, but also to enterprise-level objectives, investment decisions, and long-term value creation. LUMARES shapes decisions upstream and understands how your medical function can add value to key organisational strategy.
​
We bring extensive experience engaging directly with global health authorities and regulators, participating in strategic forums and working-level discussions on how innovative technologies and platforms should be integrated into existing regulatory and healthcare frameworks.
This experience enables us to operate as a credible partner across organisational and external boundaries, bridging enterprise strategy with regulatory and system-level realities.
Building and Scaling Medical Affairs Capabilities from Scratch
We have built Medical Affairs local, regional and global functions and capabilities end-to-end, from pre-candidate stages through to post-launch, across local, regional, and global organisations. This includes designing operating models, evidence strategies, field medical structures, and cross-functional ways of working that scale across multiple products, platforms, and therapeutic areas. Our advice is grounded in having built, led, and scaled these capabilities ourselves.
Leadership of High-Stakes, Unprecedented Global Launches
LUMARES has led some of the most complex and fast-paced launches in biopharma, including unprecedented global programmes delivered at record speed. We understand what breaks under pressure, how organisations truly behave at launch, and where traditional launch models fail. This experience informs pragmatic, impact-driven strategies that stand up in real-world conditions.
Scientific Though Leadership, Not Just Execution
LUMARES is led by a recognised scientific thought leader, with a strong publication record and active participation in scientific and advisory communities. This ensures credibility with external stakeholders, depth in scientific dialogue, and leadership that extends beyond execution into shaping how science is interpreted, positioned, and advanced. We do not separate strategy from science. Science leads.
End-to-End Perspective from Early Development to Exit or Expansion
Unlike launch-only models, LUMARES understands how early scientific and medical decisions shape downstream outcomes.
We support organisations in embedding medical and scientific strategy early to mitigate risk, preserve optionality, and position programmes for successful launch, acquisition, merger, or independent commercialisation.
This long-view perspective allows us to align development, launch readiness, and lifecycle strategy into a coherent whole.
Client Testimonials
“Lumares Strategy delivered high-level advisory and decisive leadership - transforming our Medical Affairs strategy and accelerating measurable scientific impact.”
- Global BioTech CMO
“Exceptional strategic insight and scientific expertise - instrumental in realigning investor decisions in line with long term with goals and delivering critical outcomes”
- VP, Medical Affairs, Pharma Client
“Board-level advisory that reshaped our approach and drove impactful, science-led results at a pivotal growth stage”
- Founder, Emerging Biotech